Roche (OTCMKTS:RHHBY) Rating Lowered to “Moderate Sell” at Jefferies Financial Group

Roche (OTCMKTS:RHHBY) was downgraded by equities research analysts at Jefferies Financial Group from a “hold” rating to a “moderate sell” rating in a research report issued on Monday,Zacks.com reports.

RHHBY has been the subject of several other reports. Hsbc Global Res upgraded Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 2nd. HSBC raised Roche from a “hold” rating to a “buy” rating and set a $50.00 price objective on the stock in a research note on Thursday, October 2nd. Three analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $50.00.

Roche Stock Down 0.4%

Shares of RHHBY stock opened at $42.09 on Monday. Roche has a 12 month low of $34.10 and a 12 month high of $45.94. The company has a 50 day simple moving average of $42.46 and a two-hundred day simple moving average of $40.73.

Hedge Funds Weigh In On Roche

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in RHHBY. Boston Common Asset Management LLC grew its holdings in shares of Roche by 11.1% in the second quarter. Boston Common Asset Management LLC now owns 361,833 shares of the company’s stock valued at $14,682,000 after purchasing an additional 36,101 shares in the last quarter. OLD National Bancorp IN boosted its holdings in shares of Roche by 2.9% in the second quarter. OLD National Bancorp IN now owns 261,317 shares of the company’s stock valued at $10,604,000 after purchasing an additional 7,326 shares during the period. Bard Financial Services Inc. grew its holdings in Roche by 1.3% during the 3rd quarter. Bard Financial Services Inc. now owns 138,650 shares of the company’s stock worth $5,797,000 after acquiring an additional 1,800 shares in the last quarter. Rhumbline Advisers increased its holdings in shares of Roche by 1.1% in the 2nd quarter. Rhumbline Advisers now owns 108,480 shares of the company’s stock valued at $4,422,000 after acquiring an additional 1,228 shares during the period. Finally, Yousif Capital Management LLC grew its position in shares of Roche by 7.8% in the 2nd quarter. Yousif Capital Management LLC now owns 88,547 shares of the company’s stock worth $3,593,000 after buying an additional 6,395 shares during the last quarter.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.